First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis

Italian journal of pediatrics

Volumn 40, Issue , 2014, Pages 101-

  Szarvas, Nóra ^a   Szilágyi, Ágnes ^a   Tasic, Velibor ^a   Nushi Stavileci, Valbona ^a   Sofijanova, Aspazija ^a   Gucev, Zoran ^a   Szabó, Miklós ^a   Szabó, Attila ^a   Szeifert, Lilla ^a   Reusz, György ^a   Rusai, Krisztina ^a   Arbeiter, Klaus ^a   Müller, Thomas ^a   Prohászka, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; ECULIZUMAB; MONOCLONAL ANTIBODY;

ATYPICAL HEMOLYTIC UREMIC SYNDROME; BLOOD; BLOOD COMPONENT THERAPY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FATALITY; FEMALE; GENETIC SCREENING; HUMAN; INFANT; MALE; METABOLISM; NEWBORN; PROCEDURES; PROGNOSIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ATYPICAL HEMOLYTIC UREMIC SYNDROME; BLOOD COMPONENT TRANSFUSION; COMPLEMENT SYSTEM PROTEINS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS;

EID: 85017330989     PISSN: None     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/s13052-014-0101-7     Document Type: Article

References (0)